Literature DB >> 1587810

Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging.

N Araki1, N Ueno, B Chakrabarti, Y Morino, S Horiuchi.   

Abstract

Prolonged incubation of protein with reducing sugar proceeds through a series of reactions involving early stage products to the advanced glycation end products with fluorescence, brown color, and cross-linking. Known collectively as the Maillard reaction, these changes have been suggested as factors in diabetic complications and the aging process. The early stage products have been demonstrated in vivo, but evidence for the presence in vivo of the advanced glycation end products has been limited. We sought to provide immunochemical evidence by the preparation and use of polyclonal and monoclonal antibodies to these end products (Horiuchi, S., Araki, N., and Morino, Y. (1991) J. Biol. Chem. 266, 7329-7332) as probes to identify and quantitate such compounds in human lens crystallins. Neither of the antibodies reacted with extracts from infant lenses, but fractions from adult lenses showed a significant reactivity, correlating with lens age. Our findings provide the first immunochemical evidence that human lens crystallins contain advanced glycation end products and that these products increase with tissue age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587810

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Two new prenylflavonoids from Epimedii Herba and their inhibitory effects on advanced glycation end-products.

Authors:  Keisuke Nakashima; Hiroyuki Miyashita; Hitoshi Yoshimitsu; Yukio Fujiwara; Ryoji Nagai; Tsuyoshi Ikeda
Journal:  J Nat Med       Date:  2016-01-12       Impact factor: 2.343

2.  Immunohistochemical localization of advanced glycation end products in pinguecula.

Authors:  Yuichi Kaji; Tetsuro Oshika; Shiro Amano; Fumiki Okamoto; Wakako Koito; Seikoh Horiuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-21       Impact factor: 3.117

3.  Proteomic profile of the lens in a streptozotocin-induced diabetic rat model using shotgun proteomics.

Authors:  Noriaki Nagai; Tetsushi Yamamoto; Kuniko Mitamura; Atsushi Taga
Journal:  Biomed Rep       Date:  2017-09-22

4.  Proteomic Insight Reveals Elevated Levels of Albumin in Circulating Immune Complexes in Diabetic Plasma.

Authors:  Shweta Bhat; Mashanipalya G Jagadeeshaprasad; Yugendra R Patil; Mahemud L Shaikh; Bhaskaran S Regin; Viswanathan Mohan; Ashok P Giri; Muthuswamy Balasubramanyam; Ramanamurthy Boppana; Mahesh J Kulkarni
Journal:  Mol Cell Proteomics       Date:  2016-04-07       Impact factor: 5.911

5.  Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis.

Authors:  T Matsuse; E Ohga; S Teramoto; M Fukayama; R Nagai; S Horiuchi; Y Ouchi
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

6.  Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers.

Authors:  I D Nicholl; A W Stitt; J E Moore; A J Ritchie; D B Archer; R Bucala
Journal:  Mol Med       Date:  1998-09       Impact factor: 6.354

7.  Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells.

Authors:  B Smedsrød; J Melkko; N Araki; H Sano; S Horiuchi
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

8.  Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.

Authors:  S Kume; M Takeya; T Mori; N Araki; H Suzuki; S Horiuchi; T Kodama; Y Miyauchi; K Takahashi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

9.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

Authors:  M P Vitek; K Bhattacharya; J M Glendening; E Stopa; H Vlassara; R Bucala; K Manogue; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats.

Authors:  Y Fong; D Edelstein; E A Wang; M Brownlee
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.